ACON (Aclarion) PS Ratio: 28.71 (As of Jun. 29, 2026) — 53% Above Median


ACON Aclarion Inc ACON
26 GF Score
Price $2.87
! 2 Warning Signs
View Full Analysis

What is Aclarion PS Ratio?

Aclarion ACON +2.34% 26 PS Ratio is 28.71 as of Jun. 29, 2026, which is 53% above its 10-year median of 18.81. GuruFocus rates ACON with a GF Score™ of 26/100. The stock has 2 warning signs investors should review. Among 657 Healthcare Providers & Services companies, Aclarion ranks worse than 96.19% on this metric.

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Aclarion's share price is $2.8708. Aclarion's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.10. Hence, Aclarion's PS Ratio for today is 28.71.

The historical rank and industry rank for Aclarion's PS Ratio or its related term are showing as below:

ACON' s PS Ratio Range Over the Past 10 Years
Min: 0.18   Med: 18.81   Max: 304.82
Current: 28.71

During the past 7 years, Aclarion's highest PS Ratio was 304.82. The lowest was 0.18. And the median was 18.81.

ACON's PS Ratio is ranked worse than
96.19% of 657 companies
in the Healthcare Providers & Services industry
Industry Median: 1.51 vs ACON: 28.71

Aclarion's Revenue per Sharefor the three months ended in Mar. 2026 was $0.01. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.10.

During the past 12 months, the average Revenue per Share Growth Rate of Aclarion was -99.70% per year.

Back to Basics: PS Ratio


Aclarion  (NAS:ACON) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Aclarion PS Ratio Related Terms


Aclarion PS Ratio Historical Data

* Premium members only.

The historical data trend for Aclarion's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aclarion PS Ratio Chart

Aclarion Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
PS Ratio
Get a 7-Day Free Trial 0.00 0.00 0.00 28.31 32.17

Aclarion Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.31 0.31 0.74 32.17 32.70

ACON vs WLSS, VYND, MGRX: PS Ratio Comparison

For the Health Information Services subindustry, Aclarion's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aclarion PS Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Aclarion's PS Ratio distribution charts can be found below:

* The bar in red indicates where Aclarion's PS Ratio falls into.


ACON
26GF Score
Aclarion Inc ACON
PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aclarion PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Aclarion's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=2.8708/0.1
=28.71

Aclarion's Share Price of today is $2.8708.
Aclarion's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.10.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.

Frequently Asked Questions Learn more about PS Ratio →
What does a PS Ratio of 28.71 mean?
Aclarion (ACON) has a PS Ratio of 28.71 as of Jun. 29, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Aclarion and its competitors. This is 53% above median its historical median of 18.81. Over the past decade, Aclarion's PS Ratio has ranged from 0.18 to 304.82. According to the industry distribution chart, Aclarion ranks #632 out of 657 companies in the Healthcare Providers & Services industry, placing it in the top 96.2%.
Is Aclarion's PS Ratio too high?
Aclarion's current PS Ratio of 28.71 is 53% above median its 10-year median of 18.81. Over the past 10 years, this metric has ranged from a low of 0.18 to a high of 304.82. The Healthcare Providers & Services industry median PS Ratio is 1.51. Aclarion's value of 28.71 is 1801.3% above this industry median. Based on the distribution chart, Aclarion ranks #632 out of 657 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Aclarion has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Aclarion's PS Ratio compare to WLSS and VYND?
According to the Healthcare Providers & Services industry distribution chart, Aclarion ranks #632 out of 657 companies for PS Ratio. This places Aclarion in the lower half of its industry. The industry median PS Ratio is 1.51. Aclarion's value of 28.71 is 1801.3% above this benchmark. Historically, Aclarion's own PS Ratio has ranged from 0.18 to 304.82 over the past decade. While the company's 10-year median is 18.81 vs. the industry median of 1.51, Aclarion has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Healthcare Providers & Services company?
The median PS Ratio among Healthcare Providers & Services companies is 1.51, based on 657 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aclarion's current PS Ratio of 28.71 is 1801.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Aclarion and its competitors. For the Healthcare Providers & Services industry, the median PS Ratio is 1.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aclarion's current PS Ratio is 28.71, which is 53% above median its own 10-year median of 18.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aclarion stock overvalued right now?
Aclarion (ACON) has a current PS Ratio of 28.71. The current PS Ratio is 28.71, which is 53% above median its 10-year median of 18.81 and 1801.3% above the Healthcare Providers & Services industry median of 1.51. Aclarion's overall GF Score™ is 26/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Aclarion (ACON), the current PS Ratio is 28.71 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aclarion Business Description

Other Exchanges IT20:Germany
Address 8181 Arista Place, Suite 100, Broomfield, CO, USA, 80021
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
26GF Score

Get the complete analysis for ACON

PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.87
Price